Physician profile

Hormoz Kianfar

Interventional Cardiology · Brick, NJ

NPI 1306008727

$18,739.32

in general payments reported to CMS, 2019-2025

50 companies · $5,047 in 2025

The $5,047 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$9,335.15
Travel and Lodging$1,732.81

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $3,651.16 2021-2025 Symplicity G3, Hawkone, Ffrangio
Astrazeneca Pharmaceuticals LP $2,041.22 2019-2025 Farxiga, Wainua, Lokelma
Boston Scientific Corporation $1,556.67 2019-2025 Avvigo Guidance System, Watchman Flx, Lux-Dx Insertable Cardiac Monitor
E.R. Squibb & Sons, L.L.C. $1,452.98 2019-2025 Camzyos, Eliquis
Boehringer Ingelheim Pharmaceuticals, INC. $1,354.21 2019-2025 Jardiance
Abbott Laboratories $1,203.20 2019-2025 Aveir, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $928.91 2019-2025 Lifevest
Novartis Pharmaceuticals Corporation $913.01 2019-2025
Pfizer INC. $778.15 2019-2025
Novo Nordisk INC $598.31 2022-2025 Wegovy, Rybelsus, Ozempic
Janssen Pharmaceuticals, INC $515.82 2019-2024 Xarelto
Merck Sharp & Dohme LLC $479.92 2021-2025 Verquvo, Belsomra
Shockwave Medical, INC $456.29 2022-2025 Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter
Amgen INC. $413.00 2020-2025 Repatha, Repatha
Sanofi-Aventis U.S. LLC $195.42 2019-2023
Show all 50 companies
CompanyGeneral paymentsYearsTop products
Medtronic Vascular, INC. $194.34 2019-2020
Avinger INC. $190.56 2020-2023 Pantheris
Lilly USA, LLC $163.75 2023-2025 Mounjaro, Zepbound
Amarin Pharma, INC. $159.56 2019-2023
Kowa Pharmaceuticals America, INC. $151.31 2019-2021
Abiomed $150.64 2023-2025 Impella
Astellas Pharma US INC $139.52 2019-2021
Esperion Therapeutics, INC. $120.56 2020-2025 Nexletol
Heartflow, INC. $91.08 2024-2025
Impulse Dynamics (USA) INC. $78.29 2025 Optimizer
Scpharmaceuticals INC. $75.63 2024-2025
Alnylam Pharmaceuticals INC. $48.26 2024-2025 Amvuttra, Onpattro
Cvrx, INC. $48.05 2024 Barostim Neo System
Lexicon Pharmaceuticals, INC. $43.81 2023-2024 Inpefa
Bayer Healthcare Pharmaceuticals INC. $42.20 2021-2025
Arbor Pharmaceuticals, INC. $41.24 2019-2021
Tactile Systems Technology INC $40.27 2020-2024 Entre Plus, Flexitouch Plus
Kestra Medical Technology Services, INC. $35.46 2024 Assure Wcd
Edwards Lifesciences Corporation $34.03 2022-2023
Lundbeck LLC $33.93 2019-2020
Daiichi Sankyo INC. $33.64 2022-2023 Injectafer
Kiniksa Pharmaceuticals International, Plc $32.21 2024 Arcalyst
Chiesi USA, INC. $30.39 2019-2025 Kengreal
W. L. Gore & Associates, INC. $29.55 2021
Endologix LLC $23.92 2025 Endocross Device, Torus Stent Graft System
Cashflow Solutions, LLC $21.64 2023 Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White
Medicomp INC $21.61 2024 Telepatch Cardiac Monitor
Terumo Medical Corporation $19.55 2024 Metacross Otw, Glidewire
Kiniksa Pharmaceuticals, LTD. $16.77 2023 Arcalyst
Azurity Pharmaceuticals, INC. $16.49 2024 Edarbi
Medicure Pharma INC. $15.43 2021
Veryan Medical Incorporated $15.21 2021
Angiodynamics, INC. $14.95 2024 Auryon Laser System 100-120 Vac
Cardiva Medical, INC. $14.71 2025 Cardiva Vascade 6/7f Vcs
Shionogi INC $12.49 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Hormoz Kianfar

$18,739.32

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic, INC.
Context
The $5,047 reported for 2025 was more than what 83% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/59144/hormoz-kianfar

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.